HTR3A
5-hydroxytryptamine receptor 3A
Also known as: 5-HT3A, 5-HT3R, 5HT3A_HUMAN, HTR3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46098
- Gene
- HTR3A
- Ensembl
- ENSG00000166736
- Chromosome
- 11
- Canonical length
- 478 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The product of this gene belongs to the ligand-gated ion channel receptor superfamily. This gene encodes subunit A of the type 3 receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor causes fast, depolarizing responses in neurons after activation. It appears that the heteromeric combination of A and B subunits is necessary to provide the full functional features of this receptor, since either subunit alone results in receptors with very low conductance and response amplitude. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
478 residues, UniProt reviewed canonical sequence.
>P46098|HTR3A
1 MLLWVQQALL ALLLPTLLAQ GEARRSRNTT RPALLRLSDY LLTNYRKGVR PVRDWRKPTT
61 VSIDVIVYAI LNVDEKNQVL TTYIWYRQYW TDEFLQWNPE DFDNITKLSI PTDSIWVPDI
121 LINEFVDVGK SPNIPYVYIR HQGEVQNYKP LQVVTACSLD IYNFPFDVQN CSLTFTSWLH
181 TIQDINISLW RLPEKVKSDR SVFMNQGEWE LLGVLPYFRE FSMESSNYYA EMKFYVVIRR
241 RPLFYVVSLL LPSIFLMVMD IVGFYLPPNS GERVSFKITL LLGYSVFLII VSDTLPATAI
301 GTPLIGVYFV VCMALLVISL AETIFIVRLV HKQDLQQPVP AWLRHLVLER IAWLLCLREQ
361 STSQRPPATS QATKTDDCSA MGNHCSHMGG PQDFEKSPRD RCSPPPPPRE ASLAVCGLLQ
421 ELSSIRQFLE KRDEIREVAR DWLRVGSVLD KLLFHIYLLA VLAYSITLVM LWSIWQYALocalizationUniProt · AlphaFold · HPA
Whether an antibody against HTR3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 7.5 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 7.5 nTPM
- lymph node: 6.1 nTPM
- salivary gland: 4.8 nTPM
- pancreas: 2.7 nTPM
- basal ganglia: 2.3 nTPM
- appendix: 2 nTPM
Single-cell type
- b-cells: 5.5 nCPM
- pancreatic acinar cells: 5.5 nCPM
- salivary acinar cells: 2.9 nCPM
- brain inhibitory neurons: 2.6 nCPM
- cdc: 2.4 nCPM
- pdcs: 2.1 nCPM
Immune cell
- naive B-cell: 14 nTPM
- plasmacytoid DC: 12 nTPM
- memory B-cell: 3.9 nTPM
- myeloid DC: 0.6 nTPM
- total PBMC: 0.2 nTPM
- basophil: 0 nTPM
Brain region
- basal ganglia: 1.6 nTPM
- hippocampal formation: 1.6 nTPM
- cerebral cortex: 1.2 nTPM
- amygdala: 0.7 nTPM
- white matter: 0.4 nTPM
- midbrain: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.17
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- inorganic cation transmembrane transport
- monoatomic ion transmembrane transport
- regulation of membrane potential
- serotonin receptor signaling pathway
- serotonin-gated cation-selective signaling pathway
Molecular functions
- excitatory extracellular ligand-gated monoatomic ion channel activity
- identical protein binding
- ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
- serotonin binding
- serotonin-gated monoatomic cation channel activity
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neurotransmitter-gated ion-channel transmembrane domain
- Neurotransmitter-gated ion-channel
- Neurotransmitter-gated ion-channel ligand-binding domain
- 5-hydroxytryptamine 3 receptor
- Neurotransmitter-gated ion-channel, conserved site
- Neurotransmitter-gated ion-channel transmembrane domain superfamily
- Neurotransmitter-gated ion-channel ligand-binding domain superfamily
- Neuronal acetylcholine receptor
- 5-hydroxytryptamine 3 receptor, transmembrane domain
- Neurotransmitter-gated ion-channel ligand binding domain
- Neurotransmitter-gated ion-channel transmembrane region
- 5-hydroxytryptamine 3 receptor, A subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HTR3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HTR3A as an antibody target. Whether an autoantibody or antibody against HTR3A could matter depends on whether native HTR3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HTR3A is annotated at the cell surface, where native HTR3A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HTR3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...